NACDS: “The Congress and states need no further validation for their bipartisan work to immediately confront pharmaceutical benefit manipulation that is devastating Americans, communities, and pharmacies of all sizes”
NACDS: “These harms are experienced brutally by pharmacies of diverse sizes and formats, including independents and chains, that do not receive preferential treatment from their vertically integrated plans and PBMs”
“Now is the time for Massachusetts to stop pharmaceutical benefit manipulation from inflating Bay Staters’ prescription drug prices and from jeopardizing access to trusted pharmacies and needed medications”
“Confronting the PBMs’ self-enriching tactics requires state and federal legislators and policymakers to do their part”
Wyden letter urges Centers for Medicare & Medicaid Services to “conduct immediate oversight and rigorous regulatory enforcement of specific Medicare Part D program requirements for plan sponsors and their PBMs.”
NACDS also is urging Congress to enact in the 118th Congress PBM reforms in Medicare, Medicaid and the commercial markets: all levels and branches of government must do their jobs.
“Confronting the PBMs’ self-enriching tactics requires state and federal legislators and policymakers to do their part.”
The New York Times publishes first article in a series: “The Middlemen: The Opaque Industry Secretly Inflating Prices for Prescription Drugs; Pharmacy benefit managers are driving up drug costs for millions of people, employers, and the government.”
PBMs represent a “staggering national problem.”
Urges Congress: no further delays in enacting bipartisan reforms to reduce Americans’ drug costs and to protect access to pharmacies and prescribed medications.
H. 233 includes important reforms that will help curb PBM tactics threatening Vermont patients and the pharmacies on which they rely.
Responds to RFI from Department of Justice, Department of Health and Human Services, and Federal Trade Commission.
The Massachusetts advertising campaign comes as part of NACDS’ broader advocacy work in collaboration with in-state partners.
